Li Weihua, Chen Guangyuan, Yu Xianwen, Shi Yongying, Peng Miaoguan, Wei Jianjun
Department of Infectious Disease, First Affiliated Hospital of Guangzhou Medical College, Guangzhou 510102, Guangdong Province, China.
Int J Clin Exp Pathol. 2013 May 15;6(6):1076-85. Print 2013.
Hepatitis B virus (HBV) genotype C is associated with the development of hepatocellular carcinoma (HCC). In addition, HBV subgenotype C1 is the major subgenotype in Southern China. The aim of this study was to investigate whether there was the specific mutation patterns in HBV/C1 associated with Southern Chinese patients with HCC.
Mutations in HBV basal core promoter (BCP) and their association with HCC were assessed in a matched cross-sectional control study of 102 HCC and 105 chronic hepatitis (CH) patients (from Guangdong, China) infected with HBV/C1. Functional analysis of HBx mutants was performed by the colony formation assay and the luciferase assays.
T1762/A1764 double mutations was frequently found in patients infected with HBV/C1, regardless of clinical status (64.7% in HCC and 51.4% in CH, P>0.05). Unexpectedly, the adjacent V1753 or A1768 mutation significantly increased the risk of HCC (P<0.05). Moreover, the prevalence of triple or quadruple mutations in BCP was significantly higher in patients with HCC than those with CH, particularly for HBeAg-positive-carriers (P<0.05). Functional analysis revealed that T1762/A1764 mutation alone did not alter the transcriptional activity and the inhibitory effects on cell proliferation of HBx, but triple or quadruple mutations largely abrogated this effect.
Accumulation of mutations involving V1753 or/and A1768 in addition to T1762/A1764 in BCP region were closely related to HCC among the patients infected with HBV/C1, particularly for HBeAg-positive-carriers. The increased risk of HCC caused by BCP variants may be attributable partially to modifying the biological functions of HBx.
乙型肝炎病毒(HBV)基因C型与肝细胞癌(HCC)的发生有关。此外,HBV基因C1亚型是中国南方的主要亚型。本研究的目的是调查在中国南方HCC患者中,与HBV/C1相关的特定突变模式是否存在。
在一项匹配的横断面对照研究中,对102例感染HBV/C1的HCC患者和105例慢性肝炎(CH)患者(来自中国广东),评估HBV基础核心启动子(BCP)中的突变及其与HCC的关联。通过集落形成试验和荧光素酶试验对HBx突变体进行功能分析。
无论临床状态如何,感染HBV/C1的患者中经常发现T1762/A1764双突变(HCC患者中为64.7%,CH患者中为51.4%,P>0.05)。出乎意料的是,相邻的V1753或A1768突变显著增加了HCC的风险(P<0.05)。此外,HCC患者BCP中三重或四重突变的发生率显著高于CH患者,尤其是HBeAg阳性携带者(P<0.05)。功能分析表明,单独的T1762/A1764突变不会改变HBx的转录活性和对细胞增殖的抑制作用,但三重或四重突变在很大程度上消除了这种作用。
在感染HBV/C1的患者中,除了BCP区域的T1762/A1764外,涉及V1753或/和A1768的突变积累与HCC密切相关,尤其是对于HBeAg阳性携带者。BCP变异导致的HCC风险增加可能部分归因于改变了HBx的生物学功能。